Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Perpetual Medicines is a biotechnology company focused on accelerating drug discovery through an integrated computational and experimental platform. The company leverages advanced artificial intelligence and machine learning to design and optimize novel small molecule therapeutics for challenging biological targets. By combining predictive modeling with high-throughput experimental validation, Perpetual Medicines aims to improve the efficiency and success rate of the drug development process. Their primary therapeutic focus includes oncology and autoimmune diseases, where they seek to address significant unmet medical needs. The company is led by experienced industry veterans and backed by prominent life science venture capital firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Perpetuals.com.